Biotech

All Articles

Lilly, Haya ink $1B biobuck excessive weight deal to browse darker genome

.Eli Lilly's hunt for obesity aim ats has led it to the black genome. The Big Pharma has assembled a...

ArsenalBio elevates $325M, rotates off of former lead resource

.Arsenal Biosciences is actually moving on up. The tissue therapy business has actually added $325 m...

Lilly- supported effective weight loss biotech data IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has filed to ...

Aelis' cannabis use drug fails stage 2b, steering Indivior to reassess $100M alternative

.Aelis Farma's hopes of safeguarding an easy, beneficial choice on a $100 million possibility paymen...

ProKidney standstills stage 3 test certainly not needed to have for cell treatment permission

.ProKidney has actually ceased some of a set of period 3 trials for its cell treatment for kidney il...

Vaxcyte rises on 'sensational' 31-valent PCV gain against Pfizer

.Vaxcyte revealed what experts named "impressive" phase 1/2 information for its 31-valent pneumococc...

Recursion's human brain ailment trial presents little proof of effectiveness

.Recursion has actually discovered through an early examination of its tech-enabled method to drug r...

Acepodia, Pfizer click on all together for chemistry-based tissue therapy

.Call it a case of good chemical make up: Acepodia, a biotech based upon Nobel Prize-winning scienti...

Praxis epilepsy medication decreases confiscations in period 2 trial

.Praxis Precision Medicines has racked up an additional midphase win in epilepsy this year, along wi...

Three execs surrender as Dyne blog posts blended records for DMD applicant

.After running away a professional hold numerous years back, Dyne Rehab has shown brand new phase 1/...